In routine clinical practice, few physicians use early viral kinetics to guide HCV dual therapy treatment decisions.
Mangia A, Bányai T, De Bartolomeo G, Gervain J, Habersetzer F, Mulkay JP, Ouzan D, Parruti G, Passariello N, Remy AJ, Rizzetto M, Shiffman ML, Tice AD, Schmitz M, Tatsch F, Rodriguez-Torres M.
Mangia A, et al. Among authors: tice ad.
Liver Int. 2014 Aug;34(7):e217-28. doi: 10.1111/liv.12352. Epub 2013 Nov 20.
Liver Int. 2014.
PMID: 24251988